Fry S W, Seeff L B
Department of Medicine, Georgetown University Medical Center, NW Washington, DC 20007, USA.
Gastroenterol Clin North Am. 1995 Dec;24(4):875-905.
Nearly all analgesic and anti-inflammatory agents have the potential for hepatic injury. Most nonsteroidal anti-inflammatory drugs (NSAIDs) produce injury in an unpredictable fashion by way of an idiosyncratic (immunologic versus metabolic) mechanism, whereas acetaminophen and aspirin are more predictable because they produce injury in a dose-dependent manner by way of intrinsic toxicity. Both acetaminophen and aspirin may produce hepatotoxicity despite therapeutic intent. This article discusses specific NSAIDs available in the United States and abroad and their associated hepatotoxicity and carefully considers acetaminophen-related hepatotoxicity reviewing risk factors for injury, clinical features, prognosis, and management.
几乎所有的止痛和抗炎药物都有导致肝损伤的可能性。大多数非甾体抗炎药(NSAIDs)通过特异质性(免疫性与代谢性)机制以不可预测的方式造成损伤,而对乙酰氨基酚和阿司匹林则更具可预测性,因为它们通过内在毒性以剂量依赖的方式造成损伤。尽管是出于治疗目的,但对乙酰氨基酚和阿司匹林都可能产生肝毒性。本文讨论了美国和国外可用的特定非甾体抗炎药及其相关的肝毒性,并仔细考虑了与对乙酰氨基酚相关的肝毒性,回顾了损伤的危险因素、临床特征、预后和处理方法。